Transient Ischemic Attack Market Overview
The global Transient Ischemic Attack market is projected to rise at a significant rate in the forthcoming years. A short blockage in the blood supply to a region of the brain causes a transient ischemic attack (TIA), sometimes known as a "mini-stroke." A lack of oxygen to the brain is caused by an interruption in blood supply, which causes sudden symptoms similar to a stroke, such as visual and speech disturbances, as well as numbness or weakness in the arms, face, and legs.
The global transient ischemic attack market is predicted to rise rapidly throughout the forecast period, owing to rising investments in biotechnology and pharmaceutical research, as well as growing demand for better treatment options. Furthermore, the global transient ischemic attack market is being driven by the rising frequency of neurological illnesses and the growing global elderly population.
On the negative side, over the projection period, a shortage of experienced physicians and surgeons, as well as rising treatment and hospitalization costs, are expected to hinder market expansion.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Diagnosis, Treatment, End User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services Inc., Boston Scientific Corporation, Sanofi SA, Bayer AG, Pfizer Inc., Siemens AG, GE Healthcare, Penumbra, Inc., F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Laboratories, Merck & Co., Inc., Boehringer Ingelheim GmbH, LivaNova PLC, Cyberonics, Inc, NeuroMetrix, Inc. |
Covid-19 Impact on Transient Ischemic Attack Market
In addition, the current Transient Ischemic Attack Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Transient Ischemic Attack Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Transient Ischemic Attack Market Segment Overview
According to Diagnosis, Magnetic Resonance Imaging (MRI) segment holds the largest share in the global Transient Ischemic Attack market. This is primarily attributed to better imaging quality and better suitability of the magnetic resonance imaging (MRI) technique. Furthermore, by Treatment, Drugs is one of the largest segments in the global Transient Ischemic Attack market. Drugs are the first line of treatment for curing transient ischemic attacks. Several companies are investing highly in the research and development activities for the new drug development for the treatment of transient ischemic attacks.
Transient Ischemic Attack Market, By Diagnosis
· Computed Tomography (CT) Scan
· Carotid Duplex Scanning
· Magnetic Resonance Imaging
· Echocardiography
Transient Ischemic Attack Market, By Treatment
· Drugs
· Surgery
Transient Ischemic Attack Market, By End User
· Hospitals & Clinics
· Diagnostic Centers
· Research Laboratories
Transient Ischemic Attack Regional Overview
Geographically, North America emerged as the dominant region in the global transient ischemic attack market due to factors such as the rising prevalence of neurological disorders, high per capita healthcare expenditure, increasing government support for research and development activities, and the presence of major pharmaceutical companies. Moreover, the market in the Asia Pacific is expected to rise at a considerable rate in the coming period. Major factors such as improvement in healthcare facilities and an increase in awareness relating to personal health are anticipated to boost the growth of the transient ischemic attack market in this region.
Transient Ischemic Attack Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Transient Ischemic Attack Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Transient Ischemic Attack are highlighted below.
· In August 2021, Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's Amplatzer™ Amulet™ Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic stroke. The device offers immediate closure of the left atrial appendage (LAA) – an area where blood clots can form in people suffering from AFib – reducing their risk of stroke and immediately eliminating the need for blood-thinning medication.
Transient Ischemic Attack Market, Key Players
· Koninklijke Philips N.V.
· Stryker Corporation
· Johnson & Johnson Services Inc.
· Boston Scientific Corporation
· Sanofi SA
· Bayer AG
· Pfizer Inc.
· Siemens AG
· GE Healthcare
· Penumbra, Inc.
· F. Hoffmann-La Roche AG
· Medtronic PLC
· Abbott Laboratories
· Merck & Co., Inc.
· Boehringer Ingelheim GmbH
· LivaNova PLC
· Cyberonics, Inc
· NeuroMetrix, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Transient Ischemic Attack market?
The global transient ischemic attack market is predicted to rise rapidly throughout the forecast period, owing to rising investments in biotechnology and pharmaceutical research, as well as growing demand for better treatment options.
Q2. What are the restraining factors for the global Transient Ischemic Attack market?
Over the projection period, a shortage of experienced physicians and surgeons, as well as rising treatment and hospitalization costs, are expected to hinder market expansion.
Q3. Which segment is projected to hold the largest share in the global Transient Ischemic Attack Market?
Magnetic Resonance Imaging (MRI) segment is projected to hold the largest share in the global Transient Ischemic Attack Market.
Q4. Which region holds the largest share in the global Transient Ischemic Attack market?
North America held the largest share in the global Transient Ischemic Attack market
Q5. Which are the prominent players in the global Transient Ischemic Attack Market?
Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services Inc., Boston Scientific Corporation, Sanofi SA, Bayer AG, Pfizer Inc., Siemens AG, GE Healthcare, Penumbra, Inc., F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Laboratories, Merck & Co., Inc., Boehringer Ingelheim GmbH, LivaNova PLC, Cyberonics, Inc, NeuroMetrix, Inc. are some key players in the global Transient Ischemic Attack Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Diagnosis
- 5.2.1. Computed Tomography (CT) Scan
- 5.2.2. Carotid Duplex Scanning
- 5.2.3. Magnetic Resonance Imaging
- 5.2.4. Echocardiography
- 5.3. Market Analysis, Insights and Forecast – By Treatment
- 5.3.1. Drugs
- 5.3.2. Surgery
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals & Clinics
- 5.4.2. Diagnostic Centers
- 5.4.3. Research Laboratories
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Diagnosis
- 6.2.1. Computed Tomography (CT) Scan
- 6.2.2. Carotid Duplex Scanning
- 6.2.3. Magnetic Resonance Imaging
- 6.2.4. Echocardiography
- 6.3. Market Analysis, Insights and Forecast – By Treatment
- 6.3.1. Drugs
- 6.3.2. Surgery
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals & Clinics
- 6.4.2. Diagnostic Centers
- 6.4.3. Research Laboratories
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Diagnosis
- 7.2.1. Computed Tomography (CT) Scan
- 7.2.2. Carotid Duplex Scanning
- 7.2.3. Magnetic Resonance Imaging
- 7.2.4. Echocardiography
- 7.3. Market Analysis, Insights and Forecast – By Treatment
- 7.3.1. Drugs
- 7.3.2. Surgery
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals & Clinics
- 7.4.2. Diagnostic Centers
- 7.4.3. Research Laboratories
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Diagnosis
- 8.2.1. Computed Tomography (CT) Scan
- 8.2.2. Carotid Duplex Scanning
- 8.2.3. Magnetic Resonance Imaging
- 8.2.4. Echocardiography
- 8.3. Market Analysis, Insights and Forecast – By Treatment
- 8.3.1. Drugs
- 8.3.2. Surgery
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals & Clinics
- 8.4.2. Diagnostic Centers
- 8.4.3. Research Laboratories
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Diagnosis
- 9.2.1. Computed Tomography (CT) Scan
- 9.2.2. Carotid Duplex Scanning
- 9.2.3. Magnetic Resonance Imaging
- 9.2.4. Echocardiography
- 9.3. Market Analysis, Insights and Forecast – By Treatment
- 9.3.1. Drugs
- 9.3.2. Surgery
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals & Clinics
- 9.4.2. Diagnostic Centers
- 9.4.3. Research Laboratories
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Koninklijke Philips N.V.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Stryker Corporation
- 10.6. Johnson & Johnson Services Inc.
- 10.7. Boston Scientific Corporation
- 10.8. Sanofi SA
- 10.9. Bayer AG
- 10.10. Pfizer Inc.
- 10.11. Siemens AG
- 10.12. GE Healthcare
- 10.13. Penumbra, Inc.
- 10.14. F. Hoffmann-La Roche AG
- 10.15. Medtronic PLC
- 10.16. Abbott Laboratories
- 10.17. Merck & Co., Inc.
- 10.18. Boehringer Ingelheim GmbH
- 10.19. LivaNova PLC
- 10.20. Cyberonics, Inc
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
